Propanc Biopharma, Inc Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.09-$10.81
Market Cap
$2.2M
Shares Short
201,708

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
$52.11

News

See more

Yahoo Finance • 2 months ago

Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study

About

CEO
Mr. James Nathanielsz
Address
302, 6 Butler Street, Camberwell, VIC, Australia, 3124
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1